Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.15 USD | -1.70% | -4.94% | -23.08% |
May. 30 | Transcript : CytoDyn Inc. - Special Call | |
May. 03 | CytoDyn Inc. announced that it has received $8.942 million in funding | CI |
Financials (USD)
Sales 2022 | 0.27 | Sales 2023 | - | Capitalization | 239M |
---|---|---|---|---|---|
Net income 2022 | -211M | Net income 2023 | -79M | EV / Sales 2022 | 989,524,989 x |
Net Debt 2022 | 32.57M | Net Debt 2023 | 33.01M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.02
x | P/E ratio 2023 |
-2.52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.15% |
Latest transcript on CytoDyn Inc.
1 day | -1.70% | ||
1 week | -4.94% | ||
Current month | -4.94% | ||
1 month | -2.85% | ||
3 months | -20.21% | ||
6 months | -35.43% | ||
Current year | -23.08% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | Nov. 16 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | Jan. 31 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 22-10-12 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 22-08-23 |
Karen Brunke
BRD | Director/Board Member | 72 | 22-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 0.15 | -1.70% | 3,224,228 |
24-06-06 | 0.1526 | +5.10% | 2,097,190 |
24-06-05 | 0.1452 | -1.22% | 2,883,534 |
24-06-04 | 0.147 | -0.68% | 3,649,167 |
24-06-03 | 0.148 | -6.19% | 9,734,264 |
Delayed Quote OTC Markets, June 07, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-23.08% | 159M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- CYDY Stock